Market Currents
U.S. prosecutors seek $1B to resolve a long-running probe into Johnson & Johnson's (JNJ...
-
Thursday, May 12, 2011, 1:55 PM ETU.S. prosecutors seek $1B to resolve a long-running probe into Johnson & Johnson's (JNJ +0.6%) marketing of antipsychotic drug Risperdal, WSJ reports. A $1B settlement would rank among the industry's largest, and likely have a material impact on J&J's quarterly financial results.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
